These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32616543)

  • 1. Bioactivation of
    Mulder T; Bobba S; Johnson K; Grandner JM; Wang W; Zhang C; Cai J; Choo EF; Khojasteh SC; Zhang D
    Drug Metab Dispos; 2020 Sep; 48(9):819-829. PubMed ID: 32616543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition of 1-[3-(aminomethyl)phenyl]-N-[3-fluoro-2'- (methylsulfonyl)-[1,1'-biphenyl]-4-yl]-3-(trifluoromethyl)- 1H-pyrazole-5-carboxamide (DPC 423) by novel metabolic pathways. Characterization of unusual metabolites by liquid chromatography/mass spectrometry and NMR.
    Mutlib AE; Shockcor J; Chen SY; Espina RJ; Pinto DJ; Orwat MJ; Prakash SR; Gan LS
    Chem Res Toxicol; 2002 Jan; 15(1):48-62. PubMed ID: 11800597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significantly Different Covalent Binding of Oxidative Metabolites, Acyl Glucuronides, and S-Acyl CoA Conjugates Formed from Xenobiotic Carboxylic Acids in Human Liver Microsomes.
    Darnell M; Breitholtz K; Isin EM; Jurva U; Weidolf L
    Chem Res Toxicol; 2015 May; 28(5):886-96. PubMed ID: 25803559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a Discrete Diglucuronide of GDC-0810 in Human Plasma after Oral Administration.
    Zhang C; Su D; Choo EF; Liu L; Bobba S; Jorski JD; Ho Q; Wang J; Kenny JR; Khojasteh SC; Zhang D
    Drug Metab Dispos; 2023 Oct; 51(10):1284-1294. PubMed ID: 37349116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the metabolites of rosmarinic acid in human liver microsomes using liquid chromatography combined with electrospray ionization tandem mass spectrometry.
    Su J; Jia F; Lu J; Chen W; Sun H; Liu T; Wu X
    Biomed Chromatogr; 2020 Apr; 34(4):e4806. PubMed ID: 32012312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioactivation of GPR40 Agonist MK-8666: Formation of Protein Adducts in Vitro from Reactive Acyl Glucuronide and Acyl CoA Thioester.
    Shang J; Tschirret-Guth R; Cancilla M; Samuel K; Chen Q; Chobanian HR; Thomas A; Tong W; Josien H; Buevich AV; Mitra K
    Chem Res Toxicol; 2020 Jan; 33(1):191-201. PubMed ID: 31566356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Species differences in the elimination of a peroxisome proliferator-activated receptor agonist highlighted by oxidative metabolism of its acyl glucuronide.
    Kochansky CJ; Xia YQ; Wang S; Cato B; Creighton M; Vincent SH; Franklin RB; Reed JR
    Drug Metab Dispos; 2005 Dec; 33(12):1894-904. PubMed ID: 16183782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma stability-dependent circulation of acyl glucuronide metabolites in humans: how circulating metabolite profiles of muraglitazar and peliglitazar can lead to misleading risk assessment.
    Zhang D; Raghavan N; Wang L; Xue Y; Obermeier M; Chen S; Tao S; Zhang H; Cheng PT; Li W; Ramanathan R; Yang Z; Humphreys WG
    Drug Metab Dispos; 2011 Jan; 39(1):123-31. PubMed ID: 20876787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GDC-0810 Pharmacokinetics and Transporter-Mediated Drug Interaction Evaluation with an Endogenous Biomarker in the First-in-Human, Dose Escalation Study.
    Cheung KWK; Yoshida K; Cheeti S; Chen B; Morley R; Chan IT; Sahasranaman S; Liu L
    Drug Metab Dispos; 2019 Sep; 47(9):966-973. PubMed ID: 31266752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the chemical reactivity of 2-phenylpropionic acid 1-O-acyl glucuronide and S-acyl-CoA thioester metabolites.
    Li C; Benet LZ; Grillo MP
    Chem Res Toxicol; 2002 Oct; 15(10):1309-17. PubMed ID: 12387630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioactivation of lumiracoxib in human liver microsomes: Formation of GSH- and amino adducts through acyl glucuronide.
    Jiao W; Zhao X; Wu G; Zhang X; Wu H; Cui Y
    Drug Test Anal; 2020 Jun; 12(6):827-835. PubMed ID: 32043805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cysteine amide adduct formation from carboxylic acid drugs via UGT-mediated bioactivation in human liver microsomes.
    Harada H; Toyoda Y; Endo T; Kobayashi M
    Pharmazie; 2015 Oct; 70(10):678-83. PubMed ID: 26601426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic activation of TM5441 in vitro and in vivo: Formation of reactive metabolites and human enzymes involved.
    Lang SQ; Lang WH; Yu HY; Wang L
    Eur J Pharm Sci; 2020 Feb; 143():105195. PubMed ID: 31852629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucuronidation of statins in animals and humans: a novel mechanism of statin lactonization.
    Prueksaritanont T; Subramanian R; Fang X; Ma B; Qiu Y; Lin JH; Pearson PG; Baillie TA
    Drug Metab Dispos; 2002 May; 30(5):505-12. PubMed ID: 11950779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Perspectives on Acyl Glucuronide Risk Assessment in Drug Discovery: Investigation of In vitro Stability, In situ Reactivity, and Bioactivation.
    Gunduz M; Argikar UA; Cirello AL; Dumouchel JL
    Drug Metab Lett; 2018; 12(2):84-92. PubMed ID: 29886840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quaternary ammonium-linked glucuronidation of tamoxifen by human liver microsomes and UDP-glucuronosyltransferase 1A4.
    Kaku T; Ogura K; Nishiyama T; Ohnuma T; Muro K; Hiratsuka A
    Biochem Pharmacol; 2004 Jun; 67(11):2093-102. PubMed ID: 15135306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo metabolism of a gamma-secretase inhibitor BMS-299897 and generation of active metabolites in milligram quantities with a microbial bioreactor.
    Zhang D; Hanson R; Roongta V; Dischino DD; Gao Q; Sloan CP; Polson C; Keavy D; Zheng M; Mitroka J; Yeola S
    Curr Drug Metab; 2006 Dec; 7(8):883-96. PubMed ID: 17168689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-S-acyl-glutathione thioesters: synthesis, bioanalytical properties, chemical reactivity, biological formation and degradation.
    Grillo MP
    Curr Drug Metab; 2011 Mar; 12(3):229-44. PubMed ID: 20946099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of physicochemical properties on the reactivity and stability of acyl glucuronides
    Camilleri P; Buch A; Soldo B; Hutt AJ
    Xenobiotica; 2018 Sep; 48(9):958-972. PubMed ID: 28967291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intestinal glucuronidation in limiting hepatic exposure and bioactivation of raloxifene in humans and rats.
    Dalvie D; Kang P; Zientek M; Xiang C; Zhou S; Obach RS
    Chem Res Toxicol; 2008 Dec; 21(12):2260-71. PubMed ID: 19548350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.